We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




COVID-19 Infection Fatality Ratio is Close to One Percent

By HospiMedica International staff writers
Posted on 10 Nov 2020
A new report reveals that the COVID-19 infection fatality ratio (IFR) is 1.15% in high-income countries, but substantially lower in low-income countries with younger populations. More...


Researchers at Imperial College London (Imperial; United Kingdom) screened 175 studies to update estimates of COVID-19 IFR. Based on 10 representative antibody surveys, they found that age-specific IFRs followed a log-linear pattern, with the risk of death doubling approximately every eight years of age. They estimated that overall IFR in a typical low-income country, with a population structure skewed towards younger individuals, was 0.23%. In contrast, in a typical high income country, with a greater concentration of elderly individuals, the overall IFR was 1.15%.

Age-specific IFRs increased from 0.1% for those under 40 years to greater than 5% among individuals over 80 years. When accounting for seroreversion—the waning of antibodies leading to a negative serological result-- the IFR was slightly reduced among surveys conducted several months after the first wave of the outbreak, such as in Italy. In contrast, uncertainty in test false positive rates, combined with low serological prevalence in some surveys, reconciled apparently low crude fatality ratios with the IFR in other countries. The findings were published on October 29, 2020, by the MRC Centre for Global Infectious Disease Analysis.

“Although the elderly are by far at the highest risk of dying due to COVID-19, the risk in middle age is still high. For example, we estimate that around one in 260 people aged 50-55 years die if infected,” said senior author Lucy Okell, PhD. “We calculated COVID-19 fatality largely based on the first wave of the epidemic in a number of countries, and we hope and expect to see some reduction in fatality now due to new clinical knowledge and treatment, but this remains a dangerous virus.”

“We know that antibody tests are not perfect, and there may be a considerable number of people who do not mount a detectable antibody response to SARS-CoV-2,” said study co-author Robert Verity, PhD. “However, even when this uncertainty is taken into account, we still find that COVID-19 has a high fatality rate, on the order of one percent for a typical high-income country. This risk is concentrated in older ages, with the probability of dying from COVID-19 doubling approximately every eight years.”

IFR is a key statistic for estimating disease burden, representing the proportion of deaths among all infected individuals. Previous estimates have relied on data early in the COVID-19 epidemic, or have not fully accounted for uncertainty in serological test characteristics and delays from onset of infection to seroconversion, death, and antibody waning.

Related Links:
Imperial College London


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.